AmeriCorps CEO volunteer on 9/11 Day of Service
Remarks as Prepared for CEO Michael D. Smith at the September 11 Anniversary Event
September 10, 2024 14:51 ET | AmeriCorps
Washington, DC, Sept. 10, 2024 (GLOBE NEWSWIRE) -- CEO Smith's remarks as prepared are below. I was a recent college graduate living in Washington, DC, in the fall of 2001. The sight of the gaping...
LoyalS Logo Stacked gld blk.png
Loyal Source Strengthens Veteran Affair and Medical Disability Examination Program with Two Key Hires
April 15, 2024 09:00 ET | Loyal Source Government Services
ORLANDO, Fla., April 15, 2024 (GLOBE NEWSWIRE) -- Loyal Source Government Services, one of the nation’s leading providers of healthcare solutions for federal, state, local and commercial partners,...
Veteran Service Orga
Veteran Service Organizations File Lawsuit to Compel VA to Amend its Character of Discharge Regulations
October 24, 2023 20:54 ET | Swords to Plowshares
Washington, D.C., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Today, two veterans service organizations filed a lawsuit in the U.S. Court of Appeals for the Federal Circuit to compel the U.S. Department of...
logo.png
Arch Biopartners Enters Exclusive License Agreement with the University of Cincinnati for AB569 Topical Wound Treatment
March 24, 2021 08:25 ET | Arch Biopartners
TORONTO, March 24, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today it has entered into an exclusive agreement with the...
Veteran-Owned Healthcare Company Awarded $43 Million Contract to Aide Department of Defense (DOD) and Federal Agencies
April 07, 2020 08:41 ET | Alliant Healthcare
Michigan, April 07, 2020 (GLOBE NEWSWIRE) -- Michigan-based Alliant Healthcare Products has been awarded a Laboratory ECAT contract by the Defense Logistics Agency valued at $43,750,000 over 5 years....
logo.png
Arch Biopartners Announces Issuance of U.S. Patent for Its Novel Antibacterial Drug AB569, Designed to Target Chronic Infection and Antibiotic Resistance
March 27, 2018 09:08 ET | Arch Biopartners
TORONTO, March 27, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (Arch or the Company) (TSX Venture:ARCH) (OTCBB:ACHFF), announced today that the U.S. Patent and Trademark Office has issued U.S....